Clinical trial Recruiting at 5 sites Observational Ages 4 to 120

Understanding genetic causes of inherited eye diseases

Official title: Clinical and Molecular Studies in Families With Inherited Eye Disease

Run by National Institutes of Health Clinical Center (CC) · NCT02771236 · Data updated 2026-11-12

This study is trying to find out the genetic reasons behind inherited eye diseases by looking at families with affected members and testing participants aged four and older.

Quick facts

Study typeObservational
Ages4 Years to 120 Years
SexAll
Enrollment5000 (estimated)
SponsorNational Institutes of Health Clinical Center (CC)
NIH
Locations10 sites (La Jolla, California and 9 other locations)
StatusRecruiting
StartedOctober 4, 2016
Main results expectedJanuary 1, 2032
Study endsJanuary 1, 2032
Registry record updatedNovember 9, 2026
Trial IDNCT02771236 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include individuals aged four and older who have an inherited eye disease or have a family member with such a condition.

Probably not a fit

Patients with diseases or conditions that mimic inherited eye diseases may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to identify the genetic factors linked to inherited eye diseases by examining families with affected individuals. Participants aged four and older will undergo a comprehensive evaluation, including medical history, eye exams, and genetic testing through blood and saliva samples. The research will focus on various inherited eye conditions, such as cataracts and glaucoma, to better understand their genetic underpinnings. The study will involve up to 5,000 participants from diverse backgrounds to ensure a broad understanding of these conditions.

Why it matters

Potential benefit: If successful, this research could lead to improved diagnosis and treatment options for patients with inherited eye diseases.

How similar studies have gone: Other studies have shown success in identifying genetic causes of inherited diseases, suggesting a promising approach for this research.

Who can join: the full rules

Show full inclusion / exclusion criteria
* INCLUSION CRITERIA:

To be eligible, the following inclusion criteria must be met, where applicable;

1. Participant must be four years of age or older.
2. Participant must understand and sign the protocol s informed consent document.
3. Individuals or family members of individuals with inherited eye diseases, either congenital, childhood, or age related.
4. All participants must be able to cooperate with study examination and phlebotomy.

EXCLUSION CRITERIA:

A participant is not eligible if any of the following exclusion criteria are present:

1. Participant has a disease, infection, or trauma that mimics inherited cataracts, retinal degenerations, glaucoma, etc.
2. Participant has a significant active infection (an infection requiring treatment as determined by the investigator) or a history of chronic or recurrent infections.
3. Participant requires sedation for study purposes.

Where it's running

  • University of California, San Diego
    La Jolla, California, United States
    Recruiting
  • National Institutes of Health Clinical Center
    Bethesda, Maryland, United States
    Recruiting
  • Eye Research Institute, Zhongshan Ophthalmic Center, Sun Yat Sen University
    Guangzhou, China
    Recruiting
  • University of the Philippines
    Manila, Philippines
    Recruiting
  • The Filatov Institute of Eye Disease and Tissue Therapy of the National Academy
    Odesa, Ukraine
    Recruiting
  • Duke University Eye Center
    Durham, North Carolina, United States
    Withdrawn
Show 4 more locations
  • Aravind Medical Research Foundation
    Madurai, India
    Withdrawn
  • Seconda Universita di Napoli
    Naples, Italy
    Withdrawn
  • National Centre of Excellence in Molecular Biology, University of the Punjab
    Lahore, Pakistan
    Suspended
  • University of Exeter
    Exeter, United Kingdom
    Suspended

Study contacts

  • Principal investigator: James F Hejtmancik, M.D. — National Eye Institute (NEI)
  • Study coordinator: James F Hejtmancik, M.D.
  • Email: f3h@helix.nih.gov
  • Phone: (301) 435-1598

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.